Syndax Pharmaceuticals (SNDX) PT Raised to $27 at Baird
Tweet
Share
E-mailGet Alerts SNDX Hot Sheet
Price: $20.68 --0%
Rating Summary:
18 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 4 | New: 2
Rating Summary:
18 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 4 | New: 2
Join SI Premium – FREE
Baird analyst Madhu Kumar raised the price target on Syndax Pharmaceuticals (NASDAQ: SNDX) to $27.00 (from $20.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Kepler Cheuvreux Downgrades Ipsos SA (IPS:FP) (IPSOF) to Hold
- Lululemon (LULU) PT Lowered to $106 at UBS
- Lonza Group (LONN:SW) (LZAGY) PT Raised to CHF630 at BofA Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
